NDC Code(s) : 76439-274-30
Packager : Virtus Pharmaceuticals LLC

Category : HUMAN PRESCRIPTION DRUG LABEL

DEA Schedule : none

Marketing Status : New Drug Application

INGREDIENTS AND APPEARANCE

VP CH Ultracalcium citrate, iron pentacarbonyl, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine hydrochloride, folic acid, docusate sodium and doconexent CAPSULE, GELATIN COATED
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:76439-274
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CALCIUM CITRATE(UNII: MLM29U2X85)
(CALCIUM CATION - UNII:2M83C4R6ZB) 		CALCIUM CATION104 mg
IRON PENTACARBONYL(UNII: 6WQ62TAQ6Z)
(FERROUS CATION - UNII:GW89581OWR) 		FERROUS CATION27 mg
CHOLECALCIFEROL(UNII: 1C6V77QF41)
(CHOLECALCIFEROL - UNII:1C6V77QF41) 		CHOLECALCIFEROL400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL-(UNII: WR1WPI7EW8)
(.ALPHA.-TOCOPHEROL, DL- - UNII:7QWA1RIO01) 		.ALPHA.-TOCOPHEROL, DL-30 [iU]
PYRIDOXINE HYDROCHLORIDE(UNII: 68Y4CF58BV)
(PYRIDOXINE - UNII:KV2JZ1BI6Z) 		PYRIDOXINE HYDROCHLORIDE25 mg
FOLIC ACID(UNII: 935E97BOY8)
(FOLIC ACID - UNII:935E97BOY8) 		FOLIC ACID1 mg
DOCUSATE SODIUM(UNII: F05Q2T2JA0)
(DOCUSATE - UNII:M7P27195AG) 		DOCUSATE SODIUM50 mg
DOCONEXENT(UNII: ZAD9OKH9JC)
(DOCONEXENT - UNII:ZAD9OKH9JC) 		DOCONEXENT260 mg
Inactive Ingredients
Ingredient Name Strength
ETHYL VANILLIN(UNII: YC9ST449YJ)
FD&C BLUE NO. 1(UNII: H3R47K3TBD)
FD&C RED NO. 40(UNII: WZB9127XOA)
GELATIN, UNSPECIFIED(UNII: 2G86QN327L)
GLYCERIN(UNII: PDC6A3C0OX)
WATER(UNII: 059QF0KO0R)
SOYBEAN OIL(UNII: 241ATL177A)
LECITHIN, SOYBEAN(UNII: 1DI56QDM62)
TITANIUM DIOXIDE(UNII: 15FIX9V2JP)
YELLOW WAX(UNII: 2ZA36H0S2V)
Product Characteristics
Color PURPLE (light purple) Score no score
Shape CAPSULE Size 27 mm
Flavor ORANGE Imprint Code V224
Contains
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1NDC:76439-274-3030 in 1 BOTTLE Type 0: Not a Combination Product14/04/2014
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 04/14/2014 04/15/2014

PRINCIPAL DISPLAY PANEL

Virtus
PHARMACEUTICALS

NDC: 76439-274-30

VP CH Ultra
PRENATAL / POSTNATAL

Prescription Folate

Rx

30 Softgels

PRINCIPAL DISPLAY PANEL - 100 tablets